PharMerica CORP Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2015-11-06: Form 8-K; Period of report 2015-11-06; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2015-08-07: Form 8-K; Period of report 2015-08-07; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2015-06-23: Form 8-K; Period of report 2015-06-19; Description 5.07 Submission of Matters to a Vote of Security Holders; Details 5.07.
- 2015-05-20: Form 8-K; Period of report 2015-05-14; Description 1.01 Entry into a Material Definitive Agreement; 7.01 Regulation FD Disclosure; Details 1.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2015-11-06 | 8-K | 2015-11-06 | 2.02 Results of Operations and Financial Condition | 2.02 On November 6, 2015, PharMerica Corporation (the “Company”) issued a press release announcing results of operations for the third quarter ended September 30, 2015, a copy of which is attached as Exhibit 99.1. | form8k.htm |
| 2015-08-07 | 8-K | 2015-08-07 | 2.02 Results of Operations and Financial Condition | 2.02 On August 7, 2015, PharMerica Corporation (the “Company”) issued a press release announcing results of operations for the second quarter ended June 30, 2015, a copy of which is attached as Exhibit 99.1. | form8k.htm |
| 2015-06-23 | 8-K | 2015-06-19 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 The 2015 Annual Meeting of Stockholders of PharMerica Corporation (the “Company”) was held on June 19, 2015. | form8k.htm |
| 2015-05-20 | 8-K | 2015-05-14 | 1.01 Entry into a Material Definitive Agreement; 7.01 Regulation FD Disclosure | 1.01 Entry into a Material Definitive Agreement. 7.01 On May 14, 2015, the Company issued a press release announcing the entry into the Settlement Agreement. | form8k.htm |
| 2015-05-07 | 8-K | 2015-05-07 | 2.02 Results of Operations and Financial Condition | 2.02 On May 7, 2015, PharMerica Corporation (the “Company”) issued a press release announcing results of operations for the first quarter ended March 31, 2015, a copy of which is attached as Exhibit 99.1. | d922119d8k.htm |
| 2015-03-27 | 8-K | 2015-03-27 | 1.02 Termination of a Material Definitive Agreement; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 7.01 Regulation FD Disclosure | 1.02 As disclosed in Item 5.02 hereof, which is incorporated herein by reference, the employment agreement of Mr. Glynn with Amerita has been terminated effective July 3, 2015. 5.02 On March 27, 2015, Jim Glynn, the President of Amerita, Inc. (“Amerita”) voluntarily terminated his employment with Amerita effective July 3, 2015 (the “Agreement”). 7.01 On March 27, 2015, the Corporation issued a press release announcing Mr. Glynn’s resignation. | form8k.htm |
| 2015-03-25 | 8-K | 2015-03-19 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Explanatory Note: References in this Current Report on Form 8-K to the Corporation’s 2014 Named Executive Officers do not include Jim Glynn, the President of the Corporation’s specialty home infusion pharmacy, Amerita, Inc. The incentive programs for Amerita, Inc. have not yet been determined. | form8k.htm |
| 2015-03-02 | 8-K | 2015-03-02 | 2.02 Results of Operations and Financial Condition | 2.02 On March 2, 2015, PharMerica Corporation (the “Company”) issued a press release announcing results of operations for the fourth quarter and year ended December 31, 2014, a copy of which is attached as Exhibit 99.1. | form8k.htm |